HIGHLIGHTS
- who: Carmelo Laface and colleagues from the Camberlingo Hospital, Francavilla Fontana, BR, Italy Section of Dermatology, Department of Biomedical Science and Human, University of Bari have published the research work: Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities, in the Journal: Cancers 2022, 14, 4028. of /2022/
- what: In this review the authors focus on the available systemic therapies for advanced HCC with a look toward the future. with regard to jurisdictional claims in published maps and institutional affil- The study showed that the greatest efficacy of Sorafenib was seen in those patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.